- Company Overview for GLAXOCHEM (UK) UNLIMITED (04299472)
- Filing history for GLAXOCHEM (UK) UNLIMITED (04299472)
- People for GLAXOCHEM (UK) UNLIMITED (04299472)
- More for GLAXOCHEM (UK) UNLIMITED (04299472)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
20 May 2021 | AGREEMENT2 | Notice of agreement to exemption from audit of accounts for period ending 31/12/20 | |
10 Nov 2020 | TM01 | Termination of appointment of Ciara Martha Lynch as a director on 9 November 2020 | |
21 Sep 2020 | AP01 | Appointment of Mr Alistair Robert Davidson as a director on 17 September 2020 | |
17 Sep 2020 | CS01 | Confirmation statement made on 28 August 2020 with updates | |
24 Jun 2020 | AA | Total exemption full accounts made up to 31 December 2019 | |
01 Jun 2020 | PARENT_ACC | Consolidated accounts of parent company for subsidiary company period ending 31/12/19 | |
18 Mar 2020 | TM01 | Termination of appointment of Charalampos Panagiotidis as a director on 2 March 2020 | |
18 Mar 2020 | AP01 | Appointment of Mrs Ciara Martha Lynch as a director on 2 March 2020 | |
20 Feb 2020 | GUARANTEE2 | Audit exemption statement of guarantee by parent company for period ending 31/12/19 | |
20 Feb 2020 | AGREEMENT2 | Notice of agreement to exemption from audit of accounts for period ending 31/12/19 | |
11 Sep 2019 | AA | Full accounts made up to 31 December 2018 | |
30 Aug 2019 | PSC05 | Change of details for Glaxosmithkline Sl Lp as a person with significant control on 29 August 2019 | |
29 Aug 2019 | PSC07 | Cessation of Glaxosmithkline Sl Lp as a person with significant control on 29 August 2019 | |
28 Aug 2019 | CS01 | Confirmation statement made on 28 August 2019 with updates | |
02 Aug 2019 | AP01 | Appointment of Mr Charalampos Panagiotidis as a director on 31 July 2019 | |
07 Jul 2019 | CS01 | Confirmation statement made on 23 June 2019 with no updates | |
07 May 2019 | TM01 | Termination of appointment of Simon Paul Dingemans as a director on 1 May 2019 | |
31 Jul 2018 | CS01 | Confirmation statement made on 23 June 2018 with no updates | |
10 Jul 2018 | AA | Full accounts made up to 31 December 2017 | |
06 Mar 2018 | PSC05 | Change of details for Glaxosmithkline Sl Lp as a person with significant control on 23 June 2017 | |
06 Mar 2018 | PSC09 | Withdrawal of a person with significant control statement on 6 March 2018 | |
14 Aug 2017 | AA | Full accounts made up to 31 December 2016 | |
25 Jun 2017 | CS01 | Confirmation statement made on 23 June 2017 with updates | |
18 Oct 2016 | CS01 |
Confirmation statement made on 4 October 2016 with updates
|
|
17 Jun 2016 | AA | Full accounts made up to 31 December 2015 |